New York pushes ahead with more reopenings as COVID-19 cases rise in U.S. Midwest

By Maria Caspani and Barbara Goldberg

NEW YORK (Reuters) – Governor Andrew Cuomo on Thursday announced more reopenings in New York state as new coronavirus infections remained low in what was once the U.S. hot spot of the pandemic.

Next Wednesday, New York City malls will be allowed to reopen at 50% capacity and casinos statewide can reopen at 25% capacity, Cuomo said.

“Thanks to the hard work of New Yorkers, we are at a point in our fight against this virus where we can safely reopen malls in New York City as long as they adhere to strict health and safety protocols,” Cuomo said. “Masks, enhanced air ventilation systems, and social distancing will be mandatory.”

The governor also waded into the hotly debated issue of indoor dining in New York City, saying during a conference call with reporters that the final decision rested with the state.

New York City Council Speaker Corey Johnson came out on Wednesday in favor of allowing indoor dining in the city, which is home to a thriving restaurant industry that was battered by the pandemic.

“It’s time to allow indoor dining in New York City with reduced capacity and clear guidance to ensure social distancing and safety,” Johnson said in a statement.

Cuomo said he would like to see restaurants reopen for indoor dining in the city but that compliance and enforcement remained a major hurdle in doing so.

“We open restaurants, that’s going to complicate by the hundreds if not thousands the number of establishments that need to be monitored,” he said.

Indoor dining is allowed in New York state with the exception of New York City, where more than 300 restaurateurs recently filed a class-action lawsuit seeking $2 billion in damages, according to media reports.

On Wednesday, gyms in New York City opened for the first time in months. They must operate at 33% capacity, with floors rearranged so patrons can exercise more than 6 feet (1.8 m) apart.

SHIFTING TRENDS

New York has seen by far the most deaths from COVID-19 of any U.S. state, more than 32,000, but its rate of new infections has dropped to among the lowest in the country.

Nationally, new cases of coronavirus have fallen for six weeks in a row, but infections are surging in the Midwest. Iowa, North Dakota and South Dakota are reporting the highest percentage of positive test results in the country – over 20% in each state.

Iowa, with a population of more than 3.1 million people, saw over 8,300 new cases last week, up 116%. That compared with about 4,400 new cases in New York state, which has more than 19.4 million residents, according to a Reuters analysis.

Cases also rose 27% last week in Minnesota and 34% in Indiana.

The U.S. Centers for Disease Control and Prevention has told state officials to prepare to distribute a potential coronavirus vaccine as early as October, according to documents made public by the agency on Wednesday.

The vaccines would be given first to healthcare workers, national security personnel and nursing homes, the agency said in the documents.

(Reporting by Maria Caspani and Peter Szekely in New York and Barbara Goldberg in Maplewood, New Jersey; Additional reporting by Lisa Shumaker; Editing by Peter Cooney)

U.S. CDC tells states to prep for COVID-19 vaccine distribution as soon as late October

By Manojna Maddipatla

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) has asked state public health officials to prepare to distribute a potential coronavirus vaccine to high-risk groups as soon as late October, documents published by the agency showed on Wednesday.

The timing of a vaccine has taken on political importance as U.S. President Donald Trump seeks re-election in November, after committing billions of federal dollars to develop a vaccine to prevent COVID-19, which has killed more than 180,000 Americans.

“For the purpose of initial planning, CDC provided states with certain planning assumptions as they work on state specific plans for vaccine distribution, including possibly having limited quantities of vaccines in October and November,” a CDC spokeswoman told Reuters.

The New York Times had earlier reported that the CDC had contacted officials in all 50 states and five large cities with the planning information.

The country’s top infectious disease expert Anthony Fauci earlier on Wednesday said on MSNBC that based on the patient enrollment rate in COVID-19 vaccine trials underway, there could be enough clinical data to know by November or December that one of the vaccines is safe and effective.

The documents put online by the New York Times showed the CDC is preparing for one or two vaccines for COVID-19 to be available in limited quantities as soon as late October.

The vaccines would be made available free of cost first to high-risk groups including healthcare workers, national security personnel, and nursing home residents and staff, the agency said in the documents.

Regulators around the world have repeatedly said development speed will not compromise vaccine safety, as quicker results would stem from conducting parallel trials that are usually done in sequence. But such reassurances have not convinced everyone.

Preliminary results of a survey conducted over the last three months in 19 countries showed that only about 70% of British and U.S. respondents would take a COVID-19 vaccine if available, Scott Ratzan, co-leader of a group called Business Partners to Convince, told Reuters in August.

Drug developers including Moderna Inc., AstraZeneca Plc and Pfizer Inc. are leading the race to develop a safe and effective vaccine for the respiratory illness.

The CDC documents describe two vaccine candidates that must be stored at temperatures of minus 70 and minus 20 degrees Celsius. Those storage requirements match profiles of candidates from Pfizer and Moderna.

Last month, the U.S. health department said the CDC was executing an existing contract option with McKesson Corp. to support potential vaccine distribution.

CDC Director Robert Redfield has asked state governors to expedite McKesson’s requests for building vaccine distribution centers and to consider waiving requirements that would stop them from becoming fully operational by Nov. 1, according to a recent letter obtained by Reuters.

(Reporting by Manojna Maddipatla in Bengaluru and Deena Beasley in Los Angeles; Editing by Maju Samuel, Tom Brown and Subhranshu Sahu)